GI-102

· GI Innovation, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GI-102, covering 2024-11-25 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma [Phase 2]

See pricing